![Wayne Pisano](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Wayne Pisano
Président chez
ONCOLYTICS BIOTECH INC.
Fortune : 341 007 $ au 31/05/2026
Profil
Mr. Wayne F.
Pisano is an Independent Director at Altimmune, Inc., a Chairman at Oncolytics Biotech, Inc. and a President at Pirus Biological & Vaccine Consulting.
He is on the Board of Directors at Altimmune, Inc., River Acquisition Corp.
and Chattem, Inc. Mr. Pisano was previously employed as a Chairman by Provention Bio, Inc., a President, Chief Executive Officer & Director by VaxInnate Corp., an Independent Director by IMV, Inc., a President & Chief Executive Officer by Sanofi Pasteur SA, a Vice President by Novartis Pharmaceuticals Corp., and a Senior Vice President-Vaccines by Sanofi-Aventis SA. He also served on the board at Aeras Global TB Vaccine Foundation.
He received his undergraduate degree from St. John Fisher College and an MBA from the University of Dayton.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
ONCOLYTICS BIOTECH INC. 0,24 % | 01/06/2026 | 288 306 ( 0,24 % ) | 299 838 $ | 31/05/2026 |
ALTIMMUNE, INC. 0,01 % | 01/05/2026 | 13 498 ( 0,01 % ) | 41 169 $ | 31/05/2026 |
Postes actifs de Wayne Pisano
| Sociétés | Poste | Début |
|---|---|---|
| ONCOLYTICS BIOTECH INC. | Président | - |
| ALTIMMUNE, INC. | Directeur/Membre du Conseil | 30/08/2018 |
Chattem, Inc.
 Chattem, Inc. Pharmaceuticals: MajorHealth Technology Manufactures over-the-counter health and beauty care products | Directeur/Membre du Conseil | 17/03/2010 |
River Acquisition Corp.
 River Acquisition Corp. MiscellaneousMiscellaneous Investment & acquisition co. | Directeur/Membre du Conseil | 17/03/2010 |
Pirus Biological & Vaccine Consulting | President | - |
Anciens postes connus de Wayne Pisano
| Sociétés | Poste | Fin |
|---|---|---|
| PROVENTION BIO, INC. | Président | 27/04/2023 |
| IMV INC. | Directeur/Membre du Conseil | 01/04/2021 |
Aeras Global TB Vaccine Foundation
 Aeras Global TB Vaccine Foundation Miscellaneous Commercial ServicesCommercial Services Aeras Global TB Vaccine Foundation is a non-profit organization, which engages in the development of tuberculosis vaccines in partnership with other biotech, pharmaceutical, and academic organizations. Its product pipeline includes AdS Ag85A, MTBCAV, VPM 1002, and RUTI. The company is headquartered in Rockville, MD. | Directeur/Membre du Conseil | 01/06/2019 |
VaxInnate Corp.
 VaxInnate Corp. Pharmaceuticals: MajorHealth Technology Develops novel, proprietary vaccines for infectious diseases | Directeur Général | 01/11/2016 |
| ░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Formation de Wayne Pisano
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
67
Relations au 1er degré
14
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 14 |
|---|---|
Chattem, Inc.
Chattem, Inc. Pharmaceuticals: MajorHealth Technology Manufactures over-the-counter health and beauty care products | Health Technology |
Oncolytics Biotech, Inc.
 Oncolytics Biotech, Inc. BiotechnologyHealth Technology Discovers and develops pharmaceutical products for the treatment of cancers | Health Technology |
Sanofi
 Sanofi Pharmaceuticals: MajorHealth Technology Engages in research, development and production of pharmaceuticals & vaccines | Health Technology |
Aeras Global TB Vaccine Foundation
Aeras Global TB Vaccine Foundation Miscellaneous Commercial ServicesCommercial Services Aeras Global TB Vaccine Foundation is a non-profit organization, which engages in the development of tuberculosis vaccines in partnership with other biotech, pharmaceutical, and academic organizations. Its product pipeline includes AdS Ag85A, MTBCAV, VPM 1002, and RUTI. The company is headquartered in Rockville, MD. | Commercial Services |
River Acquisition Corp.
River Acquisition Corp. MiscellaneousMiscellaneous Investment & acquisition co. | Miscellaneous |
University of Dayton
 University of Dayton Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Novartis Pharmaceuticals Corp.
 Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Manufactures medicines and provides healthcare solutions | Health Technology |
St. John Fisher College
 St. John Fisher College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
VaxInnate Corp.
VaxInnate Corp. Pharmaceuticals: MajorHealth Technology Develops novel, proprietary vaccines for infectious diseases | Health Technology |
Sanofi Pasteur
 Sanofi Pasteur BiotechnologyHealth Technology Manufactures and supplies vaccines | Health Technology |
IMV, Inc.
 IMV, Inc. BiotechnologyHealth Technology Operates as a clinical-stage immuno-oncology company | Health Technology |
Pirus Biological & Vaccine Consulting | |
Provention Bio, Inc.
 Provention Bio, Inc. Pharmaceuticals: MajorHealth Technology Operates as biopharmaceutical company that engages in intercepting and preventing immune-mediated diseases including type 1 diabetic activities | Health Technology |
Altimmune, Inc.
 Altimmune, Inc. BiotechnologyHealth Technology Develops biopharmaceuticals | Health Technology |
